Cargando…
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
The two erythropoietin (EPO) receptor forms mediate different cellular responses to erythropoietin. While hematopoiesis is mediated via the homodimeric EPO receptor (EPOR), tissue protection is conferred via a heteromer composed of EPOR and CD131. In the skeletal system, EPO stimulates osteoclast pr...
Autores principales: | Awida, Zamzam, Bachar, Almog, Saed, Hussam, Gorodov, Anton, Ben-Califa, Nathalie, Ibrahim, Maria, Kolomansky, Albert, Iden, Jennifer Ana, Graniewitz Visacovsky, Liad, Liron, Tamar, Hiram-Bab, Sahar, Brines, Michael, Gabet, Yankel, Neumann, Drorit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744753/ https://www.ncbi.nlm.nih.gov/pubmed/35008482 http://dx.doi.org/10.3390/ijms23010055 |
Ejemplares similares
-
Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022) -
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
por: Kolomansky, Albert, et al.
Publicado: (2020) -
Erythropoietin receptor in B cells plays a role in bone remodeling in mice
por: Deshet-Unger, Naamit, et al.
Publicado: (2020) -
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
por: Kolomansky, Albert, et al.
Publicado: (2020) -
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)